VivoSim Labs, Inc. Award Undrlyg Securities Amt
VivoSim Labs, Inc. (VIVS) had Award Undrlyg Securities Amt of 40.00 thousand shares as of 2025-08-11, per its DEF 14A filed 2026-08-21.
Financial Statements › Notes
ecd:AwardUndrlygSecuritiesAmt · last filed 2026-08-21
- 2025-08-11: Award Undrlyg Securities Amt 40.00K shares.
| Period end | Award Undrlyg Securities Amt |
|---|---|
| 2025-08-11 | 40.00K shares DEF 14A · filed 2026-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |